Search

everythinglearnresearchcommunity

for

Search:↓

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Early onset hair loss in young men is common and linked to family history and alcohol use.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Plant-based compounds can improve wound dressings and skin medication delivery.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Hair loss linked to prostate enlargement; stress and family history important factors.

Treatments for urinary symptoms often cause ejaculatory problems.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Many bodybuilders in Sergipe, Brazil use anabolic steroids, facing health risks like acne, irritability, and hypertension.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Provenge extends prostate cancer survival by about 4 months.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Berberine may reduce prostate enlargement by blocking inflammation.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.